Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$22.17 - $51.8 $4.42 Million - $10.3 Million
199,399 Added 253.67%
278,005 $14.4 Million
Q2 2022

Aug 11, 2022

BUY
$15.36 - $27.51 $397,839 - $712,536
25,901 Added 49.14%
78,606 $1.95 Million
Q1 2022

May 13, 2022

SELL
$22.22 - $39.12 $16,620 - $29,261
-748 Reduced 1.4%
52,705 $1.32 Million
Q4 2021

Feb 11, 2022

SELL
$18.38 - $40.5 $66,351 - $146,205
-3,610 Reduced 6.33%
53,453 $1.95 Million
Q3 2021

Nov 04, 2021

SELL
$13.18 - $19.83 $950,409 - $1.43 Million
-72,110 Reduced 55.82%
57,063 $976,000
Q2 2021

Aug 11, 2021

BUY
$9.59 - $50.88 $268,970 - $1.43 Million
28,047 Added 27.73%
129,173 $1.73 Million
Q1 2021

May 13, 2021

SELL
$49.53 - $68.4 $159,288 - $219,974
-3,216 Reduced 3.08%
101,126 $5.18 Million
Q4 2020

Feb 16, 2021

SELL
$47.25 - $65.16 $310,101 - $427,645
-6,563 Reduced 5.92%
104,342 $6.46 Million
Q3 2020

Nov 12, 2020

SELL
$46.35 - $61.69 $551,565 - $734,111
-11,900 Reduced 9.69%
110,905 $6.08 Million
Q2 2020

Aug 13, 2020

BUY
$38.58 - $65.07 $3.68 Million - $6.21 Million
95,366 Added 347.56%
122,805 $7.07 Million
Q1 2020

May 14, 2020

BUY
$32.73 - $50.78 $406,375 - $630,484
12,416 Added 82.65%
27,439 $1.1 Million
Q4 2019

Feb 14, 2020

SELL
$6.81 - $39.55 $1.1 Million - $6.41 Million
-162,013 Reduced 91.51%
15,023 $593,000
Q3 2019

Nov 14, 2019

BUY
$6.47 - $8.96 $308,295 - $426,944
47,650 Added 36.83%
177,036 $1.2 Million
Q2 2019

Aug 14, 2019

BUY
$8.31 - $14.85 $112,683 - $201,366
13,560 Added 11.71%
129,386 $1.2 Million
Q1 2019

May 15, 2019

BUY
$10.01 - $13.89 $315,124 - $437,271
31,481 Added 37.32%
115,826 $1.61 Million
Q4 2018

Feb 14, 2019

SELL
$9.15 - $12.26 $246,940 - $330,872
-26,988 Reduced 24.24%
84,345 $919,000
Q3 2018

Dec 21, 2021

BUY
$10.49 - $13.72 $137,891 - $180,349
13,145 Added 13.39%
111,333 $1.41 Million
Q3 2018

Nov 14, 2018

BUY
$10.49 - $13.72 $74,573 - $97,535
7,109 Added 7.81%
98,188 $1.24 Million
Q2 2018

Apr 21, 2020

BUY
$10.62 - $13.98 $153,788 - $202,444
14,481 Added 18.91%
91,079 $1.2 Million
Q2 2018

Aug 14, 2018

BUY
$10.62 - $13.98 $402,062 - $529,268
37,859 Added 97.73%
76,598 $1.01 Million
Q1 2018

Oct 18, 2019

BUY
$5.9 - $14.99 $69,212 - $175,847
11,731 Added 43.44%
38,739 $526,000
Q1 2018

May 15, 2018

SELL
$5.9 - $14.99 $947,127 - $2.41 Million
-160,530 Reduced 85.6%
27,008 $366,000
Q4 2017

Feb 14, 2018

SELL
$5.53 - $8.42 $709,742 - $1.08 Million
-128,344 Reduced 40.63%
187,538 $1.12 Million
Q3 2017

Nov 14, 2017

BUY
$6.5 - $10.69 $2.05 Million - $3.38 Million
315,882
315,882 $2.34 Million

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.